甲托雷克萨特:在后多布斯诉杰克逊时代的使用
Edward M Huddleston1, Kenneth G Saag
1From the Division of Clinical Immunology and Rheumatology, University of Alabama Birmingham, Birmingham, Alabama.
概括
甲托雷克萨特是一种常见的类风湿性疾病药物,由于其用于堕胎和产效应,其历史非常复杂. 最近的政策变化影响了其使用和风湿病学家在患者生殖健康中的作用.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 生殖健康 生殖健康
背景情况:
- 甲甲酸是各种类风湿性疾病的基石药物,包括类风湿性关节炎,牛皮性关节炎和全身性红斑狼.
- 最初作为化疗开发,其在炎症条件的有效性很早就被认可.
- 甲托雷克萨特还具有堕胎性质,并且是已知的催产素,在怀孕期间存在风险.
研究的目的:
- 检查美国近期堕胎政策变化对联风病治疗中甲状腺素使用的影响.
- 探索多布斯诉杰克逊妇女健康组织裁决对提供者和患者关于甲状腺素的观点的影响.
- 突出风湿病学家在解决患者性和生殖健康问题的不断变化的作用.
主要方法:
- 在生殖健康和政策变革的背景下,审查最近的文学和有关甲甲酸盐使用的数据.
- 对医疗服务提供者的观点和患者经验在Dobbs裁决后的分析.
- 讨论了风湿病学,产性和堕胎政策的交集.
主要成果:
- 最近的数据表明,多布斯裁决影响了医疗保健提供者和患者对甲状腺素的关注.
- 甲状腺素在堕胎过程中具有原性和历史性的使用使其处方和管理变得复杂.
- 人们越来越需要风湿病学家与患者就生殖健康问题进行接触.
结论:
- 美国目前的堕胎政策局面为甲状腺素的临床应用带来了独特的挑战.
- 风湿病学家越来越多地需要与甲状腺素治疗的患者进行复杂的生殖健康讨论.
- 需要进一步的研究和指导方针,以支持风湿病学家在不断变化的生殖权利中管理甲状腺素治疗.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
119
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:17Phase II Reactions: Methylation Reactions
156
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
156